Back to Search
Start Over
Precision medicine: Sustained response to erdafitinib in FGFR2‐mutant, multiply recurrent ameloblastoma.
- Source :
- Cancer Reports; Oct2022, Vol. 5 Issue 10, p1-4, 4p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 25738348
- Volume :
- 5
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Cancer Reports
- Publication Type :
- Academic Journal
- Accession number :
- 159726900
- Full Text :
- https://doi.org/10.1002/cnr2.1656